Pathophysiology and Nutritional Approaches in Polycystic Ovary Syndrome (PCOS): A Comprehensive Review

Overview

Journal Curr Nutr Rep

Specialty Nutritional Sciences

Date 2023 May 22

PMID 37213054

Authors

M Di Lorenzo

N Cacciapuoti

M S Lonardo

G Nasti

C Gautiero

A Belfiore

B Guida

M Chiurazzi

Affiliations

Soon will be listed here.

Abstract

Purpose Of Review: Polycystic ovary syndrome (PCOS) is the most common endocrine and metabolic disorder in women of reproductive age worldwide. This disease causes menstrual, metabolic, and biochemical abnormalities such as hyperandrogenism, oligo-anovulatory menstrual cycles, polycystic ovary, hyperleptinemia, insulin resistance (IR), and cardiometabolic disorders, often associated with overweight or obesity and visceral adiposity.

Recent Findings: The etiology and pathophysiology of PCOS are not yet fully understood, but insulin seems to play a key role in this disease. PCOS shares an inflammatory state with other chronic diseases such as obesity, type II diabetes, and cardiovascular diseases; however, recent studies have shown that a healthy nutritional approach can improve IR and metabolic and reproductive functions, representing a valid therapeutic strategy to ameliorate PCOS symptomatology. This review aimed to summarize and collect evidence about different nutritional approaches such as the Mediterranean diet (MedDiet) and the ketogenic diet (KD), as well as bariatric surgery and nutraceutical supplementation as probiotics, prebiotics, and synbiotics, among the others, used in patients with PCOS.

Citing Articles

Reproductive Endocrine Disorders: A Comprehensive Guide to the Diagnosis and Management of Infertility, Polycystic Ovary Syndrome, and Endometriosis.

Saleem Azam S, Vasudevan S, Saqib Bukhari W, Thadhani J, Tasneem H, Singh S Cureus. 2025; 17(1):e78222.

PMID: 40027012 PMC: 11871525. DOI: 10.7759/cureus.78222.

The Role of Diet, Glycaemic Index and Glucose Control in Polycystic Ovary Syndrome (PCOS) Management and Mechanisms of Progression.

Johnson C, Garipoglu G, Jeanes Y, Frontino G, Costabile A Curr Nutr Rep. 2025; 14(1):8.

PMID: 39753786 PMC: 11698792. DOI: 10.1007/s13668-024-00601-4.

Mangiferin ameliorates polycystic ovary syndrome in rats by modulating insulin resistance, gut microbiota, and ovarian cell apoptosis.

Yong Z, Mimi C, Yingjie L, Yichen G, Yansu Y, Zhi Z Front Pharmacol. 2024; 15:1457467.

PMID: 39376609 PMC: 11456450. DOI: 10.3389/fphar.2024.1457467.

Exploring the benefits of astaxanthin as a functional food ingredient: Its effects on oxidative stress and reproductive outcomes in women with PCOS - A systematic review and single-arm meta-analysis of randomized clinical trials.

Dogani Rodrigues V, Leme Boaro B, Fornari Laurindo L, Federighi Baisi Chagas E, de Lima E, Fornari Laurindo L Naunyn Schmiedebergs Arch Pharmacol. 2024; 398(2):1155-1169.

PMID: 39269488 DOI: 10.1007/s00210-024-03432-w.

Effects of kefir consumption on gut microbiota and health outcomes in women with polycystic ovary syndrome.

Citar Daziroglu M, Tek N, Cevher Akdulum M, Yilmaz C, Yalinay A Food Sci Nutr. 2024; 12(8):5632-5646.

PMID: 39139979 PMC: 11317752. DOI: 10.1002/fsn3.4212.

References

Barr S, Hart K, Reeves S, Sharp K, Jeanes Y . Habitual dietary intake, eating pattern and physical activity of women with polycystic ovary syndrome. Eur J Clin Nutr. 2011; 65(10):1126-32. DOI: 10.1038/ejcn.2011.81. View

Wellen K, Hotamisligil G . Inflammation, stress, and diabetes. J Clin Invest. 2005; 115(5):1111-9. PMC: 1087185. DOI: 10.1172/JCI25102. View

Leri M, Scuto M, Ontario M, Calabrese V, Calabrese E, Bucciantini M . Healthy Effects of Plant Polyphenols: Molecular Mechanisms. Int J Mol Sci. 2020; 21(4). PMC: 7072974. DOI: 10.3390/ijms21041250. View

Guo Y, Qi Y, Yang X, Zhao L, Wen S, Liu Y . Association between Polycystic Ovary Syndrome and Gut Microbiota. PLoS One. 2016; 11(4):e0153196. PMC: 4836746. DOI: 10.1371/journal.pone.0153196. View

Genazzani A, Ricchieri F, Lanzoni C . Use of metformin in the treatment of polycystic ovary syndrome. Womens Health (Lond). 2010; 6(4):577-93. DOI: 10.2217/whe.10.43. View

Chen Z, Zhao H, He L, Shi Y, Qin Y, Shi Y . Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. Nat Genet. 2010; 43(1):55-9. DOI: 10.1038/ng.732. View

Krishnan A, Muthusami S . Hormonal alterations in PCOS and its influence on bone metabolism. J Endocrinol. 2016; 232(2):R99-R113. DOI: 10.1530/JOE-16-0405. View

Lyu X, Lyu T, Wang X, Zhu H, Pan H, Wang L . The Antiobesity Effect of GLP-1 Receptor Agonists Alone or in Combination with Metformin in Overweight /Obese Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis. Int J Endocrinol. 2021; 2021:6616693. PMC: 7910049. DOI: 10.1155/2021/6616693. View

Dunaif A, Wu X, Lee A, Diamanti-Kandarakis E . Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS). Am J Physiol Endocrinol Metab. 2001; 281(2):E392-9. DOI: 10.1152/ajpendo.2001.281.2.E392. View

10.

Ezzat R, Abdallah W, Elsayed M, Saleh H, Abdalla W . Impact of bariatric surgery on androgen profile and ovarian volume in obese polycystic ovary syndrome patients with infertility. Saudi J Biol Sci. 2021; 28(9):5048-5052. PMC: 8381004. DOI: 10.1016/j.sjbs.2021.05.022. View

11.

Lindheim L, Bashir M, Munzker J, Trummer C, Zachhuber V, Leber B . Alterations in Gut Microbiome Composition and Barrier Function Are Associated with Reproductive and Metabolic Defects in Women with Polycystic Ovary Syndrome (PCOS): A Pilot Study. PLoS One. 2017; 12(1):e0168390. PMC: 5207627. DOI: 10.1371/journal.pone.0168390. View

12.

de Zegher F, Ibanez L . Early Origins of polycystic ovary syndrome: hypotheses may change without notice. J Clin Endocrinol Metab. 2009; 94(10):3682-5. DOI: 10.1210/jc.2009-1608. View

13.

Holte J, Bergh T, Berne C, Berglund L, Lithell H . Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance. J Clin Endocrinol Metab. 1994; 78(5):1052-8. DOI: 10.1210/jcem.78.5.8175959. View

14.

Mirabelli M, Chiefari E, Arcidiacono B, Corigliano D, Brunetti F, Maggisano V . Mediterranean Diet Nutrients to Turn the Tide against Insulin Resistance and Related Diseases. Nutrients. 2020; 12(4). PMC: 7230471. DOI: 10.3390/nu12041066. View

15.

Goverde A, van Koert A, Eijkemans M, Knauff E, Westerveld H, Fauser B . Indicators for metabolic disturbances in anovulatory women with polycystic ovary syndrome diagnosed according to the Rotterdam consensus criteria. Hum Reprod. 2008; 24(3):710-7. DOI: 10.1093/humrep/den433. View

16.

Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale H, Futterweit W . The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2008; 91(2):456-88. DOI: 10.1016/j.fertnstert.2008.06.035. View

17.

Facchinetti F, Unfer V, Dewailly D, Kamenov Z, Diamanti-Kandarakis E, Lagana A . Inositols in Polycystic Ovary Syndrome: An Overview on the Advances. Trends Endocrinol Metab. 2020; 31(6):435-447. DOI: 10.1016/j.tem.2020.02.002. View

18.

Che Y, Yu J, Li Y, Zhu Y, Tao T . Polycystic Ovary Syndrome: Challenges and Possible Solutions. J Clin Med. 2023; 12(4). PMC: 9967025. DOI: 10.3390/jcm12041500. View

19.

Dalamaga M, Muscogiuri G, Paganitsa G, Parvouleskou G, Syriou V, Karagkoynis P . Adherence to the Mediterranean diet is an independent predictor of circulating vitamin D levels in normal weight and non-smoker adults: an observational cross-sectional study. Int J Food Sci Nutr. 2021; 72(6):848-860. DOI: 10.1080/09637486.2021.1878488. View

20.

Homburg R, Pariente C, Lunenfeld B, Jacobs H . The role of insulin-like growth factor-1 (IGF-1) and IGF binding protein-1 (IGFBP-1) in the pathogenesis of polycystic ovary syndrome. Hum Reprod. 1992; 7(10):1379-83. DOI: 10.1093/oxfordjournals.humrep.a137577. View